Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Selection Criteria in Endovascular Thrombectomy and Thrombolytic Therapy (SECRET) Study: Development of Patient Selection Criteria Using CT Images and Accompanying Diseases for Efficient Intravenous Thrombolytic and Intra-arterial Recanalization Therapy in Acute Ischemic Stroke

NCT02964052 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT02964052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02964052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Selection Criteria in Endovascular Thrombectomy and Thrombolytic Therapy (SECRET) Study: Development of Patient Selection Criteria Using CT Images and Accompanying Diseases for Efficient Intravenous Thrombolytic and Intra-arterial Recanalization Therapy in Acute Ischemic Stroke
Lead sponsor
Yonsei University
Phase
Observational
Overall status
Completed
Start date
November 18, 2016
Completion date
August 3, 2020
Enrollment
1,359 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke